Disease Info Card

Ehlers-danlos Syndrome

Information about Ehlers-danlos Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Ehlers-danlos Syndrome

Most recent studies have shown that Ehlers-danlos Syndrome shares some biological mechanisms with aneurysm, aneurysm-dissecting, aortic-aneurysm, cicatrix, collagen-diseases, connective-tissue-diseases, contusions, cutis-laxa, dermatologic-disorders, dislocations, ehlers-danlos-syndrome-type-4, hemorrhage, hereditary-diseases, joint-laxity, marfan-syndrome, osteogenesis-imperfecta, pain, pregnancy-complications, rupture-spontaneous, vascular-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Ehlers-danlos Syndrome, and have been seen in publications frequently: Aging, Cell Adhesion, Cell Motility, Coagulation, Connective Tissue Development, Dehiscence, Excretion, Glycosylation, Hemostasis, Localization, Parturition, Pathogenesis, Platelet Aggregation, Proteolysis, Rna Splicing, Secretion, Tissue Development, Translation, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Ehlers-danlos Syndrome, such as ADAMTS2, ADAMTS4, ATP7A, B4GALT7, BGN, CHST14, COL1A1, COL1A2, COL3A1, COL5A1, COL5A2, DCN, ELN, FBN1, FN1, LOX, PLOD1, QPCT, TNC, TNXB. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.